| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6120877 | Journal of Clinical Virology | 2013 | 6 Pages |
Abstract
Serum M30-antigen can be a predictive marker for distinguishing between inactive carrier and HBeAg-negative CHB. Serum M30 levels are associated with the presence of significant inflammation, especially in patients with normal or minimally elevated ALT in CHB patients.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Chang Bum Bae, Soon Sun Kim, Seun Joo Ahn, Hyo Jung Cho, Sei Rhan Kim, Sun Young Park, Ga Won Song, Dong Joon Kim, Seong Gyu Hwang, Jin Mo Yang, Young Bae Kim, Young Nyun Park, Sung Jae Shin, Sung Won Cho, Jae Youn Cheong,